TP53 and colorectal carcinoma: Phosphatidylinositol 3-kinase (PI3K), tumor protein p53 (TP53), and methyltransferase 14 (METTL14) are also potential prognostic markers of CRC and can be used as markers of tumor occurrence, metastasis, survival, or recurrence [5,6,7].